70 Groups Call on @US_FDA to Revert Back to Meaningful Suffixes for Names of #Biosimilars | #Regulatory Focus https://t.co/jVTECX4CU2
70 Groups Call on @US_FDA to Revert Back to Meaningful Suffixes for Names of #Biosimilars | #Regulatory Focus https://t.co/jVTECX4CU2